Adjustable Length Injection Syringe

Abstract

The syringe assembly includes a syringe barrel (12) having a proximal end and a distal end, a needle hub (20) supporting a needle and coupled to the distal end of the syringe barrel (12), a movable shield (36) for sliding from a first position in which the needle is exposed at a first length, to a second position in which the needle is exposed at a second length shorter than the first length, and to a third position in which the distal end of the needle is covered, and a locking mechanism (48, 86) for sliding the shield to the third position while holding the shield in the second position and locking the shield in the third position to prevent reuse of the syringe.

Description

[Technical Field]

[0001] This application claims priority to U.S. Provisional Patent Application No. 62 / 882,277, filed August 2, 2019, which is incorporated herein by reference in its entirety. The present invention relates to a syringe having a movable member for changing the length of the exposed portion of a syringe needle for aspirating and filling the syringe for injecting a drug into a patient. The syringe includes a movable member for changing the effective length of the syringe to a desired depth for injection and for shielding the needle after use. [Background technology]

[0002] Insert a needle length ranging from 4 mm to 6 mm into the container or vial and aspirate. The needle length should be such that the needle penetrates the septum in the vial in a straight line to ensure penetration and reduce the risk of bending the needle.

[0003] Needle insertion into a patient's skin is primarily determined by the characteristics of the needle, not the features or structure of the needle support. Needle insertion into a patient's skin is generally divided into three stages that affect injection depth. The first stage corresponds to the initial contact of the needle with the skin, which deforms the tissue without puncturing the surface of the skin. The second stage represents skin puncture and relaxation when the needle insertion force ceases. The third stage involves pulling or stretching the skin outward as the needle is withdrawn.

[0004] The needle length, such as a needle having a length of approximately 4 mm to 6 mm, is adapted to inject a drug to a specified target depth in the subcutaneous region. The present invention provides a structure that allows the needle to be consistently inserted to the desired target depth. Previous injection devices have a needle or cannula supported on an axial post extending from a hub. The post forms a narrow portion and a relatively wide base that does not contact the skin during injection. In other injection delivery devices, the distal face of the hub positioned relative to the injection site can be relatively large, and a slight taper can be provided at the end. When the cannula is inserted at an angle relative to the surface of the patient's skin, the end of the hub can engage the skin.

[0005] Various injection devices have been manufactured so that the support structure does not contact the skin during injection or removal of the needle. Other devices have been proposed to be positioned so that the end face of the device contacts the surface of the skin to limit the depth of penetration into the patient.

[0006] Syringe delivery devices facilitate the self-administration of parenteral medications. An example of a delivery device is a pen needle. The needle is a component of a needle-based injection system and includes a double-ended cannula assembled into a plastic hub using adhesive. The hub has internal threads, allowing the hub to be attached to the pen injection device. Attaching the needle allows the proximal end of the cannula to penetrate the rubber septum of the medication cartridge, creating a fluid flow path. Maintaining glycemic control for many diabetic patients is achieved by administering multiple daily injections of insulin into subcutaneous (SC) tissue using a pen syringe delivery device, a convenient and discreet alternative to vials and syringes. Many syringes are commercially available in disposable or multi-use configurations, each offering a variety of patient-centric features. The distal pen needle cannula interfaces with a delivery site, providing a conduit for delivery. The design of the delivery device and needle is intended to enable consistent delivery to the target tissue space, minimize leakage of the injected substance, and reduce pain / discomfort and site effects associated with injections, such as bleeding and bruising. Key design features, needle length / gauge and hub face geometry, along with delivery system mechanism and injection technique, determine injection success.

[0007] Injections can be performed in the intradermal, subcutaneous, and intramuscular (IM) regions of the skin. For many types of injectable medications, including insulin, the SC region is preferred for administering injections.

[0008] While conventional devices are generally suitable for their intended uses, there is a continuing need for improved devices for controlling the depth of cannula penetration for delivering drugs or agents to selected target areas. Summary of the Invention

[0009] The syringe assembly relates to a device for assisting in aspirating a syringe and injecting a substance into a patient to a selected depth. In one embodiment, the syringe includes a needle having a first exposed length for aspirating the syringe and a second exposed length for injecting a substance into a patient to a desired depth. The syringe assembly also includes a movable shield that moves over the end of the needle after use and locks in an extended position to prevent accidental needle sticks.

[0010] In one embodiment, the syringe includes a syringe barrel and a needle or cannula extending from the distal end of the syringe barrel. A movable shield is engaged with the syringe for sliding movement relative to the syringe. The movable shield slides between a retracted position, in which the needle is exposed to a length suitable for filling and aspirating the syringe, and an extended position, in which the movable shield extends at least partially over the needle to limit the exposed length of the needle for injecting a patient. A base forms a mounting member for coupling to the syringe, and the movable shield slides relative to the base and over at least a portion of the needle extending from the syringe during aspirating and injection. The movable shield slides relative to the syringe from the retracted position to have an exposed length that allows the needle to penetrate a septum of a container or vial for aspirating the syringe. The movable shield can slide to a second position that exposes a selected needle length corresponding to the desired penetration depth. Once the injection is completed, the movable shield slides to the extended position and a locked position, which covers the needle after use. The shield and / or base may include one or more locking mechanisms for locking the shield in an extended position over the needle after use.

[0011] In one embodiment, the syringe includes a syringe barrel and a shield coupled to slide relative to the syringe from a first position where the needle is exposed to a first length, through a second position where the needle is exposed to a second length less than the first length, to a third position where the shield completely covers the tip of the needle.

[0012] In another embodiment, the syringe includes a syringe barrel having a shield attached to a distal end of the syringe. An arm forming a connecting member is coupled to the shield for sliding the shield between a retracted position on the syringe that exposes the length of the needle and an extended position that covers the needle. The arm is configured to slide on a base coupled to the syringe to hold the shield in one or more selected positions relative to the syringe and the syringe needle.

[0013] In one embodiment, the syringe has a shield that slides relative to the syringe between a retracted position for filling the syringe and exposing a length of the needle for injecting the medication into a patient to a selected depth, a second position in which the shield covers only a portion of the needle for injecting the medication to a shallower depth than when the shield is in the first position, and an extended position in which the shield covers the needle and locks in the extended position to prevent reuse of the syringe. A locking mechanism can be included to hold the shield in the second position during use while allowing the shield to slide to the extended position in which it is permanently locked to prevent further movement of the shield.

[0014] Another feature of the syringe is a movable shield coupled to a base for sliding movement relative to the syringe, the base being coupled to an exterior surface of the syringe. The shield and / or base have a locking mechanism for holding the shield in a partially retracted position, the locking mechanism allowing the shield to be released from the partially retracted position by applying a manual force to the shield, and the shield can be slid to an extended position to cover the distal end of the needle and permanently locked in the extended position.

[0015] The features are essentially achieved by a syringe assembly including a syringe barrel having a proximal end and a distal end, a needle bearing hub coupled to the distal end of the syringe barrel, and a movable shield member disposed on the syringe barrel, the movable shield member mounted to slide between a first position in which the needle is exposed, a second position in which the needle is at least partially covered, and a third position in which the needle is completely covered by the shield.

[0016] The syringe features a syringe barrel having a proximal end and a distal end, a needle bearing hub coupled to the distal end of the syringe barrel, and a shield that slides relative to the syringe to cover the distal end of the needle after use and lock the shield in an extended position to prevent reuse. The shield assembly includes a base coupled to the syringe and has a locking member protruding outward from the base. The shield has a sleeve sized to cover the end of the needle and an arm coupled to the base to allow the shield to slide relative to the base. The arm includes a first locking member that mates with the locking member on the base to partially hold the shield in an extended position to provide a short needle length. The locking member can be released by pushing the shield or the arm distally relative to the syringe and sliding the shield over the end of the needle, which causes the locking member on the base to engage a second locking member on the arm to lock the arm and shield in the extended position and prevent the shield from retracting or sliding proximally relative to the syringe.

[0017] A method for aspirating and filling a syringe assembly, preparing the syringe assembly for use, and preventing reuse of the syringe is provided. The method comprises providing a syringe having a proximal end and a distal end, a needle bearing hub coupled to the distal end of the syringe, and a movable shield coupled to the syringe. The shield is in a first position exposing a first length of the needle having a first length for filling the syringe. The shield slides to a second position to expose a second portion of the needle having a second length less than the first length for injecting a medication into a patient, and the shield is releasably held in the second position. The shield then slides to a third, extended position to cover the end of the needle and locks in the extended position to prevent reuse of the syringe.

[0018] These and other features of the present invention will become apparent from the following detailed description of the invention, which, taken in conjunction with the drawings, discloses various embodiments of the invention. [Brief explanation of the drawings]

[0019] Below is a brief description of the drawings.

[0020] [Figure 1] FIG. 1 is a side view of a syringe assembly in one embodiment. [Figure 2] 2 is a side view of the shield of the shield assembly of FIG. 1. FIG. [Figure 3] FIG. 3 is a side view of the base of the shield assembly. [Figure 4] FIG. 4 is a cross-sectional view of the base of the shield assembly. [Figure 5] FIG. 5 is a side view of the shield in the initial position. [Figure 6] FIG. 6 is a partial cross-sectional side view of the shield in the position of FIG. [Figure 7] FIG. 7 is a partial cross-sectional side view of the shield in a partially extended position. [Figure 8] FIG. 8 is a partial cross-sectional side view of the shield in an extended position over the needle. [Figure 9] FIG. 9 is a side view of a shield in a further embodiment. DETAILED DESCRIPTION OF THE INVENTION

[0021] The syringe assembly of the present invention refers to a syringe having a needle or cannula for injecting a drug or other substance into a patient. The terms needle and cannula are used interchangeably herein and refer to a thin, tubular member having a sharp end for insertion into a target injection site. The distal direction is toward the injection end of the syringe assembly, and the proximal direction is the opposite direction. The axial direction refers to the direction along or parallel to the longitudinal axis of the needle and needle hub, and the radial direction refers to the direction perpendicular to the axial direction.

[0022] The syringe is configured to inject the drug into the patient at a selected depth depending on the drug and the intended penetration depth. The intradermal layer in adults is generally about 2-3 mm thick, so the depth of intradermal injection ranges up to about 3 mm measured from the outer surface of the skin. The thickness of the subcutaneous layer varies depending on the patient's age, sex, body mass index (BMI), and the part of the body where the injection is performed. The subcutaneous region has an average thickness of about 7 mm to about 15 mm. Insulin can be preferably delivered to the subcutaneous region.

[0023] The syringe is suitable for use in injection methods and in methods of injecting drugs into patients. The description of the embodiments should not be considered as limiting the invention. The present disclosure is intended to enable those skilled in the art to implement the described variations of the invention without departing from the scope of the invention. Numerical limitations herein in the specification and claims are understood to be qualified by the modifier "about," and small deviations achieving equivalent results are within the scope of the invention. Features disclosed in connection with one embodiment or independent claim or limitations of a dependent claim may be combined with another embodiment or different independent claim without departing from the scope of the invention.

[0024] This disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The embodiments herein may be modified, implemented, or performed in various ways. It is also understood that the phraseology and terminology used herein are for descriptive purposes and should not be regarded as limiting. The use of "including," "comprising," or "having," and variations thereof, herein means the inclusion of additional items in addition to the items listed thereafter and their equivalents. Unless otherwise limited, the terms "connected," "coupled," and "mounted," and variations thereof, herein are used broadly and encompass both direct and indirect connections, couplings, and attachments. Additionally, the terms "connected" and "coupled," and variations thereof, are not limited to physical or mechanical connections or couplings. Furthermore, terms such as "up," "down," "below," and "over" are relative and are used to aid in illustration, but are not limiting. The embodiments are not intended to be mutually exclusive, and features of one embodiment can be combined with other embodiments unless they are mutually exclusive. Terms of degree, such as "substantially," "about," and "approximately," are understood by those skilled in the art to refer to a reasonable range around and including a given value, as well as ranges outside of the given value, such as the typical tolerance range associated with the manufacture, assembly, and use of an embodiment. The term "substantially" when referring to a structure or characteristic includes a characteristic that is mostly or completely present within the structure. Distal refers to a direction or position toward the patient end of the needle, and proximal refers to a direction or position away from the patient end of the needle, toward the user of the syringe.

[0025] Referring to the drawings, syringe assembly 10 includes a syringe barrel 12 having a proximal end 14 and a distal end 16. Proximal end 14 receives a movable plunger 18 and a stopper for dispensing a substance contained in the syringe assembly.

[0026] A needle hub 20 is coupled to the distal end 16 of the syringe barrel 12, as shown in FIG. 1. The needle hub 20 includes a syringe and a needle 22 extending axially from the needle hub. The needle hub 20 is configured to couple to the distal end of the syringe barrel 12. In the embodiment shown, the needle hub 20 has a substantially cylindrical body 24 having a proximal end 26 and a distal end 30 with an outwardly extending radial flange 28.

[0027] The needle shield assembly 32 is coupled to the syringe and slides from an initial retracted position shown in FIG. 5 to an intermediate position shown in FIG. 7 to an extended position shown in FIG. 8 that covers the distal end of the needle after use, preventing reuse of the syringe and preventing inadvertent needle sticks. The needle shield assembly 32 includes a base 34 for coupling to the syringe and a movable shield 36 for covering the needle after use. In the embodiment shown, the movable shield 36 slides relative to the base 34 and relative to the syringe 12.

[0028] 3 and 4 , the base 34 is configured to couple to the syringe and allow the shield 36 to slide relative to the base 34 and relative to the syringe and needle. The base 34 in the illustrated embodiment is coupled to the syringe hub 20 by snapping onto the radial flange 28. The base 34 forms a mounting structure for coupling the shield and the shield to the syringe for sliding movement relative to different positions on the syringe and needle. The base 34 includes a body 38 and a mounting member, illustrated as a cylindrical sleeve 40. The body 38 is configured to receive and attach the shield so that the shield can slide longitudinally relative to the syringe and base. The sleeve 40 has a configuration for coupling to the syringe barrel 12. In the illustrated embodiment, the sleeve 40 has a substantially cylindrical shape with a central opening sized for coupling to the syringe barrel. The sleeve 40 is attached to the syringe barrel to resist axial movement and separation of the sleeve relative to the syringe barrel 12 during normal use. The sleeve 40 can be directly coupled to the syringe in a manner that allows the shield to be rotated on the syringe to a position selected by the user. In one embodiment, the sleeve 40 is secured to the syringe barrel 12 by a suitable mechanical mechanism or by adhesion, such as glue or welding.

[0029] The base 34 includes a pair of spaced-apart side walls 42 that form a longitudinal passageway 43 or gap for receiving the shield and allow the shield to slide longitudinally within the passageway 43. The side walls 42 have upper ends with longitudinally extending, inwardly projecting flanges 44. A bottom wall 46 extends between the side walls 42 that form the passageway 43 and forms an open portion between the side walls 42 that opens at the upper end of the base. The flanges 44, side walls 42, and bottom wall 46 capture the shield 36 for sliding movement relative to the syringe and needle.

[0030] A locking mechanism is included in the base 34 for holding the shield in one or more selected positions relative to the base and syringe. In the embodiment shown, the locking mechanism is in the form of a latch that holds the shield 36 in a selected position until the latch is released, allowing the shield to slide proximally to another position. The locking mechanism in the embodiment shown is a spring-biased finger 48 having a proximal end connected to the base 34 by a spring hinge 50, which allows the finger 48 to bend inward toward the bottom wall 46 of the base 34 and bias the finger 48 outward from the bottom wall of the base. The finger 48 has a distal end with a tab 52 having a distal surface 54 and a proximal surface 56. As shown in FIG. 4 , the distal surface 54 defines the leading surface of the finger 48. The proximal surface 56 in the embodiment shown is angled relative to the longitudinal axis of the base 34 and angled outward in the distal direction. The substantially flat end surface 56 of the tab 52 is shown substantially parallel to the longitudinal axis of the finger 48 and the longitudinal axis of the base 34 .

[0031] The sleeve 40 is configured to couple the base 34 to the syringe and mount the shield 36 for sliding movement relative to the base and syringe. The sleeve 40 has a longitudinally extending central opening 60 dimensioned to receive the distal end of the syringe. A coupling mechanism is included in the central opening 60, shown in FIG. 4, to couple the sleeve 40 to the syringe. The coupling mechanism can be one or more detents 62 on the inner surface of the sleeve that protrude inwardly to engage and capture the flange 28 of the needle hub. The detents 62 are longitudinally spaced from the end wall 63 and form recesses 65 to receive and capture the flange 28 of the syringe barrel 12. In one embodiment, the coupling mechanism can be a snap connection that inhibits or prevents separation of the base 34 from the syringe barrel 12 and needle hub 20. The detents 62 shown in FIG. 4 can have angled or sloped proximal faces to slide over the radial flange 28 of the syringe. In other embodiments, the coupling mechanism can be an annular ring that can form a snap or interference connection.

[0032] The sleeve 40 in the illustrated embodiment has an open proximal end for receiving the distal end of the needle hub and the radial flange 28 when the base 34 is coupled to the needle hub or syringe. In one embodiment, the sleeve is shaped and sized to receive the distal end of the needle hub, allowing the needle to extend distally from the distal end of the sleeve. The passageway 60 can be open at the distal end, as shown in FIG. 4, and the distal end 30 of the needle hub can protrude from the distal end of the sleeve 40. In one embodiment, the sleeve 40 has a longitudinal length complementary to that of the needle hub, such that the distal end 30 of the needle hub is aligned with the distal end of the sleeve. Alternatively, the distal end 30 of the needle hub can be slightly recessed relative to the distal end of the sleeve. In other embodiments, the sleeve can have an end wall with an opening sized to allow the needle to pass through and contact the distal end of the needle hub.

[0033] Shield 36, as shown in FIG. 2, has a shield body 37 having a substantially cylindrical shape and an open axial passageway 64 with an open proximal end 66 and a distal end wall 68. End wall 68 has a central opening 70 sized to allow a needle to extend through shield 36 a sufficient length to fill and aspirate the syringe and inject medication into a patient. Open proximal end 66 is sized to receive the distal end of sleeve 40, which can slide into open proximal end 66, as shown in FIG. 5.

[0034] The shield 36 includes an arm 72 attached to a side of the shield 36, extending proximally therefrom, and spaced radially outward from the wall of the shield relative to the central axis of the shield 36. The arm 72 couples to the base 34 and is configured to slide relative to the base and syringe to guide the shield during longitudinal movement of the shield. In the embodiment shown, the arm 72 has a distal end 74 coupled to the side wall of the shield 36 and a proximal end 76. A thumb tab 78 is formed on the proximal end 76 for manipulating the shield and manually pushing the shield distally relative to the syringe and needle. A rib 80 projects from the opposite side of the arm and extends longitudinally to mate with the flange 44 on the side wall 42 of the base 34. The flange 44 contacts an upper surface of the rib 80 to capture the arm 72 within the open passage 43 of the base formed by the side wall 42, flange 44, and bottom wall 46. The arm can slide longitudinally relative to the syringe and needle within the passageway 43 relative to the base. In the embodiment shown, the arm 72 has a substantially straight distal portion 82 and an angled proximal portion 84.

[0035] The arm 72 includes a locking member that mates with the locking member on the base 34 to hold the shield in a selected position relative to the base and syringe, cover the distal end of the needle after use, and lock the shield in an extended position to prevent reuse of the syringe. The locking member includes a mechanism that mates with the spring finger 48 on the base 34. The locking mechanism is located at the distal end of the arm 72 near the shield 36 to hold the shield in a first position and release the shield when a force is applied to the end of the arm, allowing the arm to slide distally within the base. The locking mechanism in the illustrated embodiment has a recess 86 for mating with the tab 52 on the spring finger 48. In one embodiment, the recess 86 is formed by a first detent 88 and a second detent 90 spaced from the first detent 88. In other embodiments, the recess can be formed in the surface of the arm. The locking mechanism is formed by the detent 88, the recess 86, and the detent 90.

[0036] The first detent 88 is spaced from a distal surface 91 of a radial rib 93 extending from the shield 36, as shown in FIG. 2, to form a recessed region 95. The first detent 88 has a leading surface 92 angled relative to the longitudinal axis of the arm 72 and a rear proximal surface 94. Although the proximal surface 94 is shown as being angled to complement the angle of the surface 54 of the spring finger 48, the proximal surface can be substantially perpendicular to the plane of the arm. The proximal surface 94 has a shape and configuration to mate with the distal surface 54 of the finger 48. The second detent 90 has a configuration that forms a recess 86 and is spaced from the first detent 88 a distance that receives the tab 52 of the finger. The second detent 90 has a leading surface 96 and a proximal surface 98.

[0037] The second detent 90 can have a suitable configuration to allow the tab 52 of the finger 48 to slide over the second detent 90 by applying sufficient distal force to the arm. A leading surface 96 of the detent 90 has a surface with a configuration that allows the finger to slide distally over the detent. A trailing proximal surface 98 of the detent 90 can have a suitable configuration to limit sliding of the arm over the finger 48 in a proximal direction toward the proximal end of the base and to resist sliding in a proximal direction. In the embodiment shown, the second detent 90 has a rounded distal surface 96 and a rounded proximal surface 98 for sliding over the spring finger 48 when a distal force is applied. The recess 86 is configured to receive the tab 52 of the spring finger 48 when the shield 36 and arm 72 are in an intermediate position relative to the base and syringe, as shown in FIG. 7 relative to the initial position shown in FIG. 6 .

[0038] The arm's second locking member mates with the spring finger 48, locking the arm in an extended position over the distal tip of the needle after use. The second locking member includes a protrusion or detent 100 spaced from the first locking member and positioned proximal to the first locking member toward the proximal end of the arm. The detent 100 has an angled distal surface 102 and a proximal surface 104. The angled distal surface 102 has a length that allows the spring finger 48 to slide upward over the surface of the distal surface by applying an axial force to the proximal end of the arm 72. The proximal surface 104 in the illustrated embodiment is angled to engage the tab 52 of the spring finger 48, preventing the arm 72 from sliding proximally backward relative to the base 34 and syringe, and locking the shield in an extended position over the tip of the needle. Arm 72 has a longitudinal length that slides distally relative to the syringe and a distance that covers the distal end of the needle.

[0039] During use, the base 34 is coupled to the syringe as shown in FIG. 5, with the base 34 connected to the distal end of the syringe and the shield 36 in the retracted position. In the retracted position, the distal end of the body of the sleeve 40 is received in the proximal open end of the shield 36. As shown in FIGS. 5 and 6, the needle protrudes a distance from the distal end of the shield to fill the syringe and inject the medication into the patient. The tab 56 of the spring finger 48 is received in the recessed area 95 of the shield when the shield 36 is in a proximal position relative to the syringe. In one embodiment, the needle has an exposed length extending approximately 6-8 mm from the distal end of the shield 36 when the shield is in the initial, retracted, proximal position shown in FIGS. 5 and 6. In one embodiment, the needle has an exposed length of approximately 6 mm when the shield is in the proximal retracted position. In the retracted position, the tab 52 of the spring finger 48 is positioned forward or distal to the detent 88 to hold the shield in the retracted position. The syringe can be used in the configurations of FIGS. 5 and 6, in which the shield 36 forms a limiter that limits the penetration depth of the needle's exposed length. The needle 22 has an exposed length that extends from the shield when the shield is in the proximal position shown in FIG. 6, allowing the syringe to be filled by penetrating the vial's septum. Needle lengths less than 6 mm are generally difficult to fill from vials because the needle length may not be sufficient to penetrate the septum, especially when the needle penetrates the septum at an angle. Thus, in the embodiment shown, the needle has an exposed length of at least 6 mm when the shield is in the proximal position.

[0040] After filling the syringe, the shield 36 can be slid to the second intermediate position shown in FIG. 7 by the user pushing the proximal end of the arm 72 distally. The beveled tip surface 92 of the detent 88 slides over the proximal surface 56 of the tab 52 of the spring finger 48, thereby biasing the spring finger toward the base and snapping the tab 52 into the recess 86. Sliding the tab 52 into the recess 86 can provide an audible or tactile indication to the user that the shield is in the second intermediate position shown in FIG. 7. In one embodiment, the exposed length of the needle extending from the shield is about 4 mm to about 5 mm, typically about 4 mm when the shield is in the intermediate position of FIG. 7. In other embodiments, the needle has an exposed length of about 3 mm to about 5 mm when the shield is in the intermediate position of FIG. 7. The exposed length of the needle is determined by the position of the recess 86 relative to the arm. The needle shield also forms a limiter that limits the axial length of the exposed portion of the needle during injection. The recess 86 captures the tab 52 of the finger 48 with sufficient resistance to hold the shield and arm in an intermediate position during use.

[0041] After injection, arm 72 is pushed forward distally relative to the syringe, causing tab 52 to separate from recessed position 86 and slide over second detent 90. Detent 100 slides over spring finger tab 52 to the position shown in FIG. 8, and the shield slides over the distal end of the needle. Proximal portion 84 of arm 72 is at an angle relative to distal portion 82 to center the shield away from the needle, as shown in FIG. 8, so that the distal tip of the needle is no longer aligned with opening 66 in the shield's end wall. Distal surface 54 of tab 52 engages the proximal surface of detent 100 to cover the end of the needle and lock the shield in the extended position to prevent reuse of the syringe.

[0042] Another embodiment shown in FIG. 9 includes a shield 110 similar to that of the previous embodiment. Like the previous embodiment, the shield 110 includes an arm 112 and a sleeve 114 coupled to the arm for covering the end of the needle. Like the previous embodiment, the shield 110 is coupled to the base 34 for sliding movement on the base in a linear direction relative to the syringe and needle. The sleeve 114 has an open proximal end 116 sized to receive the distal end of the needle hub of a syringe and an open distal end 118 to allow the needle to protrude a distance to inject a medication into a patient.

[0043] The arm 112 in the embodiment of FIG. 9 is similar to the arms of the previous embodiment, except that it includes a set of two or more detents forming a locking mechanism for positioning the shield in a selected position relative to the needle hub and needle to expose different needle lengths depending on the intended needle penetration depth. The arm 112 has a first locking mechanism 120 at the distal end of the arm 112 and a second locking mechanism 122 spaced proximally from the first locking mechanism 120. The first and second locking mechanisms are configured to mate with the spring fingers 48 to hold the shield in a selected position relative to the base 34 and syringe. The first locking mechanism 120 includes a distal detent 124 and a proximal detent 126 spaced apart to form a recess 128. The distal detent 124 has a sloped leading distal surface 130 for sliding over the spring fingers and a trailing proximal surface for preventing the shield from sliding proximally relative to the base. The recess 128 is sized sufficiently to receive the tab of the spring finger to hold the shield in a selected position during use. The second locking mechanism 122 is similar and includes a distal detent 132 and a proximal detent 134 that form a recess 136. The detents are substantially similar to capture the tab of the spring finger and hold the shield in a selected position relative to the base and syringe.

[0044] During use, the shield 110 is received in the opening in the base 34 and positioned in the retracted position to expose a first length of the needle that can be aspirated and filled with a medication by a syringe. The syringe can be used by inserting the needle into a patient and injecting a medication to a depth corresponding to the exposed length of the needle. The shield is retracted to a first extended position by sliding the shield distally relative to the syringe until the spring fingers snap into the recesses 128, and the shield can be held in a partially extended position to expose a length of the needle that is shorter than the initial exposed length. By way of example, the initial exposed length of the needle can be approximately 6 mm, and the exposed length of the needle can be approximately 4 mm in the partially extended position. The shield can be extended to a second position in which the fingers are received in the recesses 128 of the second locking mechanism 122 to expose a shorter length of the needle that is less than the initial length and less than the length when the spring fingers are received in the recesses of the first locking mechanism 120. The exposed length of the needle when the spring fingers are received in the recesses of the second locking mechanism can be, for example, about 2 mm. After use, the shield slides to an extended distal position where the shield covers the end of the needle and the proximal locking detent 138 locks the arms and shield in the extended position to prevent reuse in a manner similar to the previous embodiment.

[0045] The foregoing embodiments and advantages are merely illustrative and should not be construed as limiting the scope of the present invention. The description of alternative embodiments is intended as an example and not as a limitation on the scope of the present invention. Various modifications, alternatives, and variations will be apparent to those skilled in the art and are intended to be included within the scope of the present invention. It is particularly noted that features of different embodiments and claims may be combined with each other unless they are mutually inconsistent. Accordingly, all such modifications are intended to be included within the scope of the present invention as defined by the appended claims and their equivalents.

Claims

1. 1. A syringe assembly comprising: a syringe having a proximal end and a distal end, and a needle extending from the distal end of the syringe; a shield disposed on the syringe to slide between a first position where a first length of the needle is exposed for filling the syringe, a second position where a locking mechanism holds the shield in the first position to expose a second length of the needle that is shorter than the first length, and a third position where a locking mechanism locks the shield in the third position and covers the needle; a base having a sleeve having a first longitudinal passage for coupling to the syringe and a body for slidably receiving the shield, the body having a second longitudinal passage; a spring-biased finger in the second longitudinal passage, the spring-biased finger having a distal end extending toward a distal end of the base and configured to bend inward relative to the base; Preparation, The shield has an arm extending from a proximal end thereof, the arm being received within the second longitudinal passage of the body for sliding relative to the front base, the arm having a recess on an inner surface at the distal end thereof for receiving a distal end of the spring-biased arm finger of the base to hold the shield in the second position. , syringe assembly.

2. 2. The syringe assembly of claim 1, wherein the recess is configured to lock the shield in the second position, allow the shield to slide to the third position, cover the needle, and lock the shield in the third position to prevent it from sliding toward the proximal end of the syringe.

3. The syringe assembly of claim 2 , wherein the base is coupled to a needle hub at the distal end of the syringe, the base being rotatable relative to the syringe.

4. 1. A syringe assembly comprising: a syringe having a proximal end and a distal end, and a needle extending from the distal end of the syringe; a shield disposed on the syringe to slide between a first position where a first length of the needle is exposed for filling the syringe, a second position where a locking mechanism holds the shield in the first position to expose a second length of the needle that is shorter than the first length, and a third position where a locking mechanism locks the shield in the third position and covers the needle; a base having a sleeve having a first longitudinal passage for coupling to the syringe and a body for slidably receiving the shield, the body having a second longitudinal passage; a spring-biased finger in the second longitudinal passage, the spring-biased finger having a distal end extending toward a distal end of the base and configured to bend inward relative to the base; Preparation, the shield has an arm extending from a proximal end thereof, the arm being received within the second longitudinal passage of the body for sliding relative to a front base, the arm having a recess on an inner surface at the distal end thereof for receiving a distal end of the spring-biased arm finger of the base to hold the shield in the second position; the locking mechanism includes the spring-biased finger that engages with the arm of the shield to hold the shield in the first position, holds the shield in the second position where the shield is releasable from the spring-biased finger in the second position, and locks the shield in the third position to prevent the shield from moving proximally relative to the syringe.

5. 5. The syringe assembly of claim 4, wherein the spring-biased fingers are biased outwardly from the base for engaging the arms of the shield.

6. 6. The syringe assembly of claim 5, wherein the spring-biased finger includes a spring hinge at a proximal end of the base for biasing the spring-biased finger outwardly from the base.

7. 2. The syringe assembly of claim 1, wherein the arm includes a plurality of spaced detents on an inner wall of the arm, and the spring-biased finger on the base selectively engages one of the detents on the arm to retain the shield in the first position, the second position, and the third position.

8. 1. A syringe assembly comprising: a syringe having a proximal end and a distal end, and a needle extending from the distal end of the syringe; a shield disposed on the syringe to slide between a first position where a first length of the needle is exposed for filling the syringe, a second position where a locking mechanism holds the shield in the first position to expose a second length of the needle that is shorter than the first length, and a third position where a locking mechanism locks the shield in the third position and covers the needle; a base having a sleeve having a first longitudinal passage for coupling to the syringe and a body for slidably receiving the shield, the body having a second longitudinal passage; a spring-biased finger in the second longitudinal passage, the spring-biased finger having a distal end extending toward a distal end of the base and configured to bend inward relative to the base; Preparation, the shield has an arm extending from a proximal end thereof, the arm being received within the second longitudinal passage of the body for sliding relative to a front base, the arm having a recess on an inner surface at the distal end thereof for receiving a distal end of the spring-biased arm finger of the base to hold the shield in the second position; the arm includes a plurality of spaced detents on an inner wall of the arm, the spring-biased finger on the base selectively engaging one of the detents on the arm to retain the shield in the first position, the second position, and the third position; the plurality of detents on the arm include a first detent at a distal end of the arm, the spring-biased finger on the base releasably engaging the first detent to retain the shield in the first position with a first length of the needle exposed; a second detent spaced proximally from the first detent, the spring-biased finger on the base engaging the second detent on the arm to hold the shield in the second position; The second detent slides over the spring-biased finger of the base to position the shield to lock it in the third position, whereby the shield covers the distal end of the needle.

9. the first detent has sloped distal and proximal surfaces and is configured to engage the spring-biased finger of the base to prevent sliding movement of the shield in a proximal direction relative to the syringe; and a second detent spaced proximally from the first detent and having a sloped distal surface defining the recess to retain the shield in the second position and allow the shield to slide distally relative to the syringe to the third position; and a third detent on an interior surface of the arm at a proximal end of the arm.

10. 10. The syringe assembly of claim 9, wherein the third detent has a sloped distal surface for sliding over the spring-biased finger and a proximal surface oriented to engage the distal end of the spring-biased finger of the base to lock the shield in the extended third position.

Images